Jay R. Luly - Dec 1, 2024 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
President and CEO, Director
Signature
/s/ Matthew Kowalsky as attorney-in-fact
Stock symbol
ENTA
Transactions as of
Dec 1, 2024
Transactions value $
-$32,929
Form type
4
Date filed
12/3/2024, 06:28 PM
Previous filing
Nov 27, 2024
Next filing
Dec 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTA Common Stock Tax liability -$32.9K -3.83K -0.47% $8.60 807K Dec 1, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit awards granted on November 20, 2020 and November 19, 2021.